On September 4 of 2020, the groundbreaking ceremony of the second Solopharm pharmaceutical plant was held. The second plant will produce medicines in tablets and capsules forms.

Planned investment volume in the project is 3.5 billion rubles. The planned launch date is 1st quarter of 2022. The production capacity of the lines will be 2 billion tablets per year.
Due to the innovative engineering solutions of German designers from d/g consultants GmbH, the plant will be built using modular glass partitions or “flexible walls”. This will allow to change the configuration of premises in a few days without stopping production process and to respond rapidly to the market trends.